Past Trials
Access our list of past trials
-
Ambrx_ACE-Breast-03
A Global, Phase 2 Study of ARX788 in HER2-Positive Metastatic Breast Cancer Patients who were previously treated with T-DXd
Study Link: https://clinicaltrials.gov/ct2/show/NCT04829604
-
Eucure YH003004
A phase II, multi-center, open-label study to evaluate the safety and efficacy of YH003 in combination with Toripalimab (anti-PD-1 mAb) in patients with unresectable / metastatic melanoma and pancreatic ductal adenocarcinoma (PDAC)
Study Link: https://clinicaltrials.gov/ct2/show/NCT05031494
Eucure YH003005
A Multicenter, Open-Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors
Study Link: https://clinicaltrials.gov/ct2/show/NCT05176509
Click here to access a list of Current Trials
Click here to access a list of Ongoing Trials (Not Recruiting)